Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Chloroquine Diphosphate for the Treatment of Hospitalized Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV2: a Phase IIb, Double-blind, Randomized Adaptive Clinical Trial

NCT04323527 is registered in ClinicalTrials.gov with Fundação de Medicina Tropical Dr. Heitor Vieira Dourado as lead sponsor.

NCT NCT04323527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04323527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Chloroquine Diphosphate for the Treatment of Hospitalized Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV2: a Phase IIb, Double-blind, Randomized Adaptive Clinical Trial
Lead sponsor
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Phase
Phase 2
Overall status
Completed
Start date
March 23, 2020
Completion date
June 7, 2020
Enrollment
278 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov infection, severe acute respiratory syndrome (sars) pneumonia